The global Head and Neck Cancer (HNC) Therapeutics Market is anticipated to surpass a remarkable worth of US$ 1.58 Billion in 2023, with a compound annual growth rate (CAGR) of 12.6% from 2023 to 2033. Developments in the detection and treatment of head and neck cancer (HNC) are expected to propel market expansion as they …
Category Archives: Healthcare Trends
Pork Tapeworm Infection Treatment Market is likely to register CAGR of 8% by 2033
The global pork tapeworm infection treatment market will grow at an 8% CAGR from 2023 to 2033, reaching US$ 25.17 billion in 2033, according to Future Market Insights. The market is expected to grow further as the number of test kits and devices increases. The market for the treatment of pig tapeworm infection is likely …
Continue reading “Pork Tapeworm Infection Treatment Market is likely to register CAGR of 8% by 2033”
Intraocular Lymphoma Treatment Market is expected to reach US$ 2.3 billion by 2033
By 2023, the global intraocular lymphoma treatment market is estimated to be worth US$ 1.2 billion. According to market research firm Future Market Insights, the market will be worth US$ 2.3 billion by 2033 and will rise at a 6.7% CAGR. Intraocular lymphomas are rare tumours that can cause a variety of clinical signs. Its …
Severe Asthma Treatment Market is expected to reach US$ 36.18 billion by 2033, at a CAGR of 5.1%
According to Future Market Insights, the global severe asthma treatment market is predicted to develop at a CAGR of 5.1% from 2023 to 2033. By 2033, the global market for severe asthma therapy is estimated to reach a value of US$ 36.18 billion. The discovery of biologics and other targeted medicines has transformed the treatment …
Germany in Respiratory Pathogen Testing Kits Market is projected to reach US$ 552.6 Million by 2033 at a CAGR of 6.0%
As per the latest market research conducted by FMI, the global Respiratory Pathogen Testing Kits Market is expected to record a CAGR of 5.7% from 2023 to 2033. In 2023, the market size is projected to reach a valuation of US$ 4083.1 million. By 2033, the valuation is anticipated to reach US$ 7136.8 million. The …
China in Transcutaneous Monitors Market is projected to grow at a CAGR rate of 4.1% from 2022 to 2029
By the end of 2029, the Transcutaneous Monitors Market is projected to generate sales revenue of US$ 540.1 Mn, representing a 4.3% CAGR from its anticipated market value in 2022 of US$ 401.8 Mn. Multichannel transcutaneous monitors are expected to command a sizeable market share of over 92.9% in 2021, according to Future Market Insights’ …
Mucosal Atomization Devices Market is expected to reach US$ 837.7 Million by 2029 at a CAGR of 8.0%
Future Market Insights has published a new market research study on the Mucosal Atomization Devices Market that analyses the worldwide industry from 2014 to 2021 and evaluates market opportunities from 2022 to 2029. The mucosal atomization devices market was estimated to be worth US$ 490.2 million in 2022, and it is anticipated to grow to …
Japan in Surgical Retractors Market is expected to grow at a CAGR of 9.3% from 2022 to 2032 to reach a valuation of US$ 202 Million
The Global Surgical Retractors Market was valued at US$ 1.8 Bn in 2021 and is expected to reach US$ 4.1 Bn by 2032, finds Future Market Insights (FMI) in a recent market survey. As per the findings of the report, it is projected that revenue through the neurosurgery application will grow at 10.7% CAGR during the forecast period. Around 12% of all neurology patients die from these …
Japan Pessary Market is expected to reach a valuation of US$ 30 Million by 2032 register a CAGR of 12.7%
The Pessary Market revenues were estimated at US$ 289.8 Mn in 2021 and is anticipated to grow at a CAGR of 10.2% from 2022-2032, according to a recently published Future Market Insights report. By the end of 2032, the market is expected to reach a valuation of US$ 831.3 Mn. The vaginal pessary is one …
Europe dominates the Biosimilars And Biologics Market share by acquiring 41% from 2022 to 2032
The Biosimilars And Biologics Market is expected to grow at a CAGR of 15.5% during the period 2022-2032. The market is valued at US$ 22,490.62 Mn in 2022 and is expected to reach a valuation of US$ 95,021.37 Mn by 2032. FMI, in its business report, elaborates the historical and current scenario of the global Biosimilars and …